ABOUT GATEWAY LANTERN
Clarity at the point of uncertainty.
Gateway Lantern Analytics provides independent scientific diligence for early-stage therapeutic assets and biomedical technologies.
Our Preclinical Intelligence Assessment helps teams judge what the evidence supports, where the thesis could fail, and which experiments should shape the next development decision.
How we approach the work
Evidence before advocacy
Supporting findings are weighed alongside contradictory evidence, failed analogues and the strongest alternative explanations.
Explicit uncertainty
Direct evidence is separated from inference, modeling and hypothesis. Computational analysis informs evidence triage; it does not establish experimental proof.
Decisions before volume
The work concentrates on the risks, experiments and evidence gates that can change a program’s next step.
Who we support
Biotech founders and investors, academic investigators and university spinouts, technology-transfer teams, incubators, accelerators, and licensing decision-makers.
Our role
Scientific diligence and preclinical intelligence. The work is analytical and advisory, with laboratory validation, formal patent and freedom-to-operate opinions, and other specialist professional services outside the engagement’s scope.